Literature DB >> 19547630

Quality of life and occupational disability in endocrine orbitopathy.

Katharina A Ponto1, Susanne Pitz, Norbert Pfeiffer, Gerhard Hommel, Matthias M Weber, George J Kahaly.   

Abstract

BACKGROUND: In endocrine orbitopathy (EO), disfiguring proptosis and diplopia impair patients' quality of life both at home and at work.
METHODS: From late 2006 to the beginning of 2008, 250 outpatients in an interdisciplinary thyroid and eye clinic filled out a questionnaire about their quality of life, occupational disability, and use of psychotherapy. 400 physicians who referred their EO patients to the clinic also participated in a survey on these issues.
RESULTS: 45% of the patients complained of restrictions in their daily activities, and 38% reported impaired self-perception. 36% were on sick leave because of EO. 28% were disabled, 5% had retired early, and 3% had lost their jobs. Patients with severe EO and motility disorders were on sick leave for longer times and were more likely to be disabled. 21% underwent psychotherapy. Patients who had been on sick leave for a long time and/or were disabled were more likely to undergo psychotherapy. Among the physicians answering the survey, 75% stated that they were taking care of temporarily disabled patients, while 34% were taking care of permanently disabled patients. 38% were treating EO patients who were undergoing psychotherapy.
CONCLUSIONS: These data indicate that patients with EO suffer considerable emotional stress and occupational impairment and point to the need for preventive care and rapid rehabilitation.

Entities:  

Keywords:  Graves’ disease; endocrine orbitopathy; impaired earning capacity; occupational disability; quality of life

Mesh:

Year:  2009        PMID: 19547630      PMCID: PMC2689575          DOI: 10.3238/arztebl.2009.0283

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  12 in total

Review 1.  [Update on endocrine orbitopathy].

Authors:  K A Ponto; G J Kahaly; S Pitz
Journal:  Klin Monbl Augenheilkd       Date:  2009-02-10       Impact factor: 0.700

Review 2.  Cost estimation of thyroid disorders in Germany.

Authors:  George J Kahaly; Markus Dietlein
Journal:  Thyroid       Date:  2002-10       Impact factor: 6.568

3.  Modification of the classification of the eye changes of Graves' disease.

Authors:  S C Werner
Journal:  Am J Ophthalmol       Date:  1977-05       Impact factor: 5.258

4.  The management of strabismus in adults--III. The effects on disability.

Authors:  George R Beauchamp; Bradley C Black; David K Coats; Robert W Enzenauer; Amy K Hutchinson; Richard A Saunders; John W Simon; David R Stager; David R Stager; M Edward Wilson; Jitka Zobal-Ratner; Joost Felius
Journal:  J AAPOS       Date:  2005-10       Impact factor: 1.220

5.  The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample.

Authors:  Polyxane Mertzanis; Linda Abetz; Krithika Rajagopalan; Derek Espindle; Robin Chalmers; Christopher Snyder; Barbara Caffery; Timothy Edrington; Trefford Simpson; J Daniel Nelson; Carolyn Begley
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

6.  [Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components].

Authors:  S Merkesdal; J L Huelsemann; T Mittendorf; S Zeh; H Zeidler; J Ruof
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

Review 7.  Psychological implications of Graves' orbitopathy.

Authors:  I Coulter; S Frewin; G E Krassas; P Perros
Journal:  Eur J Endocrinol       Date:  2007-08       Impact factor: 6.664

8.  Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL.

Authors:  C B Terwee; M N Gerding; F W Dekker; M F Prummel; W M Wiersinga
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

9.  Chronology of Graves' ophthalmopathy in an incidence cohort.

Authors:  G B Bartley; V Fatourechi; E F Kadrmas; S J Jacobsen; D M Ilstrup; J A Garrity; C A Gorman
Journal:  Am J Ophthalmol       Date:  1996-04       Impact factor: 5.258

10.  Sick leave and work disability in patients with early arthritis.

Authors:  Elisabeth J M Zirkzee; Arina C Sneep; Petronella D M de Buck; Cornelia F Allaart; Andreas J Peeters; H Karel Ronday; Marie Louise Westedt; Saskia le Cessie; Theodora P M Vliet Vlieland
Journal:  Clin Rheumatol       Date:  2007-05-10       Impact factor: 2.980

View more
  14 in total

1.  Orbital decompression for Graves' orbitopathy in England.

Authors:  P Perros; T Chandler; C M Dayan; A J Dickinson; P Foley; J Hickey; C J Macewen; J H Lazarus; J McLaren; G E Rose; J M Uddin; B Vaidya
Journal:  Eye (Lond)       Date:  2011-12-09       Impact factor: 3.775

2.  Ocular changes and approaches of ophthalmopathy in basedow - graves- parry- flajani disease.

Authors:  George Saraci; Anamaria Treta
Journal:  Maedica (Buchar)       Date:  2011-04

Review 3.  The pathophysiology of thyroid eye disease: implications for immunotherapy.

Authors:  Raymond S Douglas; Shivani Gupta
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

4.  Measuring quality of life in oculoplastic patients.

Authors:  Edward Ridyard; Clare Inkster
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

5.  [Graves' ophthalmopathy from the internist's perspective].

Authors:  K Laubner; W A Weber; J Seufert
Journal:  Ophthalmologe       Date:  2011-05       Impact factor: 1.059

6.  [Endocrine ophthalmopathy. A visible psychophysical complaint].

Authors:  I Strempel
Journal:  Ophthalmologe       Date:  2016-02       Impact factor: 1.059

7.  Predictive Factors for Changes in Quality of Life after Steroid Treatment for Active Moderate-to-Severe Graves' Orbitopathy: A Prospective Trial.

Authors:  Elena Hoppe; Alan Chun Hong Lee; David Hoppe; George J Kahaly
Journal:  Eur Thyroid J       Date:  2020-07-02

8.  Clinical efficacy of transcutaneous triamcinolone acetonide injection for upper eyelid retraction and swelling in patients with thyroid eye disease.

Authors:  Ai Kozaki; Hiroshi Nakamura; Toshu Inoue
Journal:  Int Med Case Rep J       Date:  2018-11-09

9.  Risk Factors Associated with the Activity and Severity of Graves' Ophthalmopathy among Patients at the University of the Philippines Manila-Philippine General Hospital.

Authors:  Annabelle Marie Lat; Maria Cristina Jauculan; Charisse Ann Sanchez; Cecilia Jimeno; Cherrie Mae Sison-Peña; Mary Rose Pe-Yan; Paulo Ma Pagkatipunan; Armida Suller; Marianne Cena
Journal:  J ASEAN Fed Endocr Soc       Date:  2017-09-07

10.  Real-World Efficacy and Safety of Mycophenolate Mofetil in Active Moderate-to-Sight-Threatening Thyroid Eye Disease.

Authors:  Nicole Quah Qin Xian; Ahmed Alnahrawy; Rashmi Akshikar; Vickie Lee
Journal:  Clin Ophthalmol       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.